SurvivorNet on MSN
A breakthrough for muscle-invasive bladder cancer: Padcev plus Keytruda drug combo could transform treatment around surgery
Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC)—and after decades with few major advances, newly presented data may signal a turning point in how the disease is treated.
Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...
Fistula surgery recovery takes time. After this type of outpatient surgery, a person will need rest before they can return to their usual activities. While a fistula can happen anywhere in the body, ...
VVF survivors in Kaduna. Picture credit: Supreme Magazine. Closing the fistula is only the first step. Without economic empowerment, social reintegration, and community acceptance, many survivors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results